Patients had localised pancreatic cancer but were not eligible for surgery. Following high-dose, MRI-guided radiotherapy with ...

Swedish Egetis Therapeutics has secured FDA approval for its rare disease drug Emcitate, clearing the way for a US launch ...

German pharmaceutical company Biontech will close its facilities in Tübingen, Marburg and Idar-Oberstein after failing to ...

An Alzheimer’s research project led by associate professor Sebastian Palmqvist at Lund University has been awarded 19.4 ...

Tavapadon, marketed under the brand name Juvmo, has been given the green light by the US Food and Drug Administration (FDA).

SciLifeLab is expanding its operations at Campus Solna by more than 9,000 square metres. Akademiska Hus is investing around ...

ResoTher Pharma is taking its lead candidate RTP-026 into a larger international study after seeing encouraging efficacy ...

Experience the highlights of ZEISS Medical Days 2026 in Oberkochen in this compact event recap. Manufacturers and experts ...

Nanexa has signed a global licensing deal with Danish pharmaceutical giant Novo in an agreement that could be worth up to SEK ...

Following its major Phase III setback earlier this year, Diamyd Medical is reporting new positive data. A long-term follow-up ...

MEMBER ANNOUNCEMENT - ZEISS Medical Technology advances its ZEISS Retina Workflow with digital and surgical enhancements, and ...

Novartis is expanding its radiopharmaceutical pipeline through a licensing agreement with Chinese BoomRay Therapeutics worth ...